Compare PTCT & SON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | SON |
|---|---|---|
| Founded | 1998 | 1899 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.9B |
| IPO Year | 2006 | 2014 |
| Metric | PTCT | SON |
|---|---|---|
| Price | $72.07 | $47.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 9 |
| Target Price | ★ $80.65 | $60.13 |
| AVG Volume (30 Days) | ★ 1.3M | 1.1M |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 4.39% |
| EPS Growth | 264.48 | ★ 510.30 |
| EPS | N/A | ★ 0.68 |
| Revenue | $264,734,000.00 | ★ $7,518,753,000.00 |
| Revenue This Year | N/A | $0.10 |
| Revenue Next Year | $17.70 | $1.82 |
| P/E Ratio | ★ N/A | $70.35 |
| Revenue Growth | 36.19 | ★ 41.72 |
| 52 Week Low | $43.18 | $38.65 |
| 52 Week High | $87.50 | $58.44 |
| Indicator | PTCT | SON |
|---|---|---|
| Relative Strength Index (RSI) | 53.96 | 41.85 |
| Support Level | $68.49 | $46.04 |
| Resistance Level | $73.17 | $49.16 |
| Average True Range (ATR) | 2.40 | 1.27 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 70.34 | 42.45 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.